Stem cell therapy for retinal diseases: Update

Stem Cell Research and Therapy

Volumn 2, Issue 6, 2011, Pages

  Siqueira, Rubens ^a,b,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Rubens Siqueira Research Center   (Brazil)

^c Retina Cell   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 2; NEUROFILAMENT PROTEIN; NEURON SPECIFIC ENOLASE;

CELL RENEWAL; CELL TRANSDIFFERENTIATION; DIABETIC RETINOPATHY; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; GLAUCOMA; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PARACRINE SIGNALING; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DISEASE; RETINA ISCHEMIA; RETINA MACULA AGE RELATED DEGENERATION; RETINAL STEM CELL; RETINITIS PIGMENTOSA; REVIEW; STARGARDT DISEASE; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; BONE MARROW CELL; CYTOLOGY; ENDOTHELIUM CELL; REGENERATIVE MEDICINE; TRANSPLANTATION;

MAMMALIA;

BONE MARROW CELLS; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STEM CELLS; REGENERATIVE MEDICINE; RETINAL DISEASES; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84855306455     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt91     Document Type: Review

References (100)

1. Modification of acute irradiation injury in mice and guinea-pigs by bone marrow injections. Lorenz E, Congdon C, Uphoff D, Radiology 1951 58 863 877
2. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Till JE, McCulloch EA, Radiat Res 1961 14 213 222 10.2307/3570892 13776896
3. Possible mechanisms of retinal function recovery with the use of cell therapy with bone marrow-derived stem cells. Siqueira RC, Voltarelli JC, Messias AM, Jorge R, Arq Bras Oftalmol 2010 73 474 479 10.1590/S0004-27492010000500019 21225138
4. The stem cell challenge. Lanza R, Rosenthal N, Sci Am 2004 290 93 99
5. Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Mimeault M, Batra SK, Stem Cells 2006 24 2319 2345 10.1634/stemcells.2006-0066 16794264 (Pubitemid 44679695)
6. Neural induction of adult bone marrow and umbilical cord stem cells. Ortiz-Gonzalez XR, Keene CD, Verfaillie C, Low WC, Curr Neurovasc Res 2004 1 207 213 10.2174/1567202043362342 16181071
7. The production and directed differentiation of human embryonic stem cells. Trounson A, Endocr Rev 2006 27 208 219 10.1210/er.2005-0016 16434509
8. Simple anatomy of the retina. Kolb H, Webvision: The Organization of the Retina and Visual System [Internet] Salt Lake City, UT: University of Utah Health Sciences Center; 1995 to 1 May 2005, Kolb H, Fernandez E, Nelson R, http://webvision.med.utah.edu/book/part-i-foundations/simple-anatomy-of-the- retina/ [updated 1 May 2007]
9. Potential application of adult stem cells in retinal repair-challenge for regenerative medicine. Machalinska A, Baumert B, Kuprjanowicz L, Wiszniewska B, Karczewicz D, Machalinski B, Curr Eye Res 2009 34 748 760 10.1080/ 02713680903050592 19839868
10. Leading causes of certification for blindness and partial sight in England & Wales. Bunce C, Wormald R, BMC Public Health 2006 6 58 10.1186/1471-2458-6-58 16524463
11. Age related macular degeneration. Chakravarthy U, Evans J, Rosenfeld PJ, BMJ 2010 340 981 10.1136/bmj.c981 20189972
12. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomized controlled trials. Maier PC, Funk J, Schwarzer G, Antes G, Falck-Ytter YT, BMJ 2005 331 134 10.1136/bmj.38506.594977.E0 15994659 (Pubitemid 41003170)
13. Interventions for diabetic macular oedema: a systematic review of the literature. O'Doherty M, Dooley I, Hickey-Dwyer M, Br J Ophthalmol 2008 92 1581 1590 10.1136/bjo.2008.144550 18952646
14. Management of diabetic retinopathy: a systematic review. Mohamed Q, Gillies MC, Wong TY, JAMA 2007 298 902 916 10.1001/jama.298.8.902 17712074 (Pubitemid 47311296)
15. Current approaches and future prospects for stem cell rescue and regeneration of the retina and optic nerve. Dahlmann-Noor A, Vijay S, Jayaram H, Limb A, Khaw PT, Can J Ophthalmol 2010 45 333 341 10.3129/i10-077 20648090
16. Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineagenegative hematopoietic stem cells. Otani A, Dorrell MI, Kinder K, Moreno SK, Nusinowitz S, Banin E, Heckenlively J, Friedlander M, J Clin Invest 2004 114 765 774 15372100 (Pubitemid 39578735)
17. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Otani A, Kinder K, Ewalt K, Otero FJ, Schimmel P, Friedlander M, Nat Med 2002 8 1004 1010 10.1038/nm744 12145646 (Pubitemid 35033705)
18. Autologous bone marrow-derived stem cells transplantation for retinitis pigmentosa. Siqueira RC, Messias A, Voltarelli JC, Scott I, Jorge R, Cytotherapy 2010 12 Suppl 1 58
19. Autologous Bone Marrow-Derived Stem Cells Transplantation for Retinitis Pigmentosa. ClinicalTrials.gov identifier: NCT01068561. http://clinicaltrials. gov/ct2/show/NCT01068561
20. Autologous transplantation of retinal pigment epithelium in age related macular degeneration. Siqueira RC, Arq Bras Oftalmol 2009 72 123 130 10.1590/S0004-27492009000100027 19347139
21. Behaviour of stem cells in eyes of rabbits with chorioretinal injuries caused by laser red diode 670N-M. Siqueira RC, Abad L, Benson G, Sami M, Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), 2008, Fort Lauderdale. Invest Ophthalmol Vis Sci 2008 49 536
22. Stem cells as tools in regenerative therapy for retinal degeneration. Enzmann V, Yolcu E, Kaplan HJ, Ildstad ST, Arch Ophthalmol 2009 127 563 571 10.1001/archophthalmol.2009.65 19365041
23. Deterministic regulation of hematopoietic stem cell self-renewal and differentiation. Müller-Sieburg CE, Cho RH, Thoman M, Adkins B, Sieburg HB, Blood 2002 100 1302 1309 12149211 (Pubitemid 34864285)
24. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Ratajczak MZ, Kucia M, Reca R, Majka M, Janowska-Wieczorek A, Ratajczak J, Leukemia 2004 18 29 40 10.1038/sj.leu.2403184 14586476 (Pubitemid 38159436)
25. Purification and characterization of mouse hematopoietic stem cells. Spangrude GJ, Heimfeld S, Weissman IL, Science 1988 241 58 62 Erratum in Science 1989, 244:1030 10.1126/science.2898810 2898810
26. Paracrine effects of cell transplantation: strategies to augment the efficacy of cell therapies. Cheng AS, Yau TM, Semin Thorac Cardiovasc Surg 2008 20 94 101 10.1053/j.semtcvs.2008.04.003 18707640
27. CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Nielsen JS, McNagny KM, Microcirculation 2009 16 487 496 10.1080/10739680902941737 19479621
28. Adult stem cells as an alternative source of multipotential (pluripotential) cells inregenerative medicine. Kuçi S, Kuçi Z, Latifi-Pupovci H, Niethammer D, Handgretinger R, Schumm M, Bruchelt G, Bader P, Klingebiel T, Curr Stem Cell Res Ther 2009 4 107 117 10.2174/157488809788167427 19442195
29. Mouse hematopoietic stem cell identification and analysis. Challen GA, Boles N, Lin KK, Goodell MA, Cytometry A 2009 75 14 24 19023891
30. Hematopoietic stem cell transplantation for autoimmune diseases in developing countries: current status and future perspectives. Voltarelli JC, Ouyang J, Bone Marrow Transplant 2003 32 Suppl 1 69 71 12931247
31. Applications of flow cytometry to hematopoietic stem cell transplantation. Voltarelli JC, Mem Inst Oswaldo Cruz 2000 95 403 414 10800200
32. Intravitreal autologous bone marrow-derived mononuclear cell transplantation: a feasibility report. Jonas JB, Witzens-Harig M, Arseniev L, Ho AD, Acta Ophthalmol 2008 86 225 226 10.1111/j.1600-0420.2007.00987.x 17900263
33. Intravitreal autologous bone marrow-derived mononuclear cell transplantation. Jonas JB, Witzens-Harig M, Arseniev L, Ho AD, Acta Ophthalmol 2010 88 131 132 10.1111/j.1755-3768.2009.01569.x 19604156
34. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Siqueira RC, Messias A, Voltarelli JC, Scott IU, Jorge R, Retina 2011 31 1207 1214 10.1097/IAE. 0b013e3181f9c242 21293313
35. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A, International Society for Cellular Therapy, Cytotherapy 2005 7 393 395 10.1080/14653240500319234 16236628 (Pubitemid 41671625)
36. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repaircurrent views. Phinney DG, Prockop DJ, Stem Cells 2007 25 2896 2902 10.1634/stemcells.2007-0637 17901396 (Pubitemid 350127874)
37. Retinal incorporation and differentiation of mesenchymal stem cells intravitreally injected in the injured retina of rats. Castanheira P, Torquetti L, Nehemy MB, Goes AM, Arq Bras Oftalmol 2008 71 644 650 10.1590/S0004- 27492008000500007 19039457
38. Differentiation of rat mesenchymal stem cells transplanted into the subretinal space of sodium iodateinjected rats. Gong L, Wu Q, Song B, Lu B, Zhang Y, Clin Experiment Ophthalmol 2008 36 666 671 10.1111/j.1442-9071.2008. 01857.x 18983552
39. Human neural stem cell transplantation attenuates apoptosis and improves neurological functions after cerebral ischemia in rats. Zhang P, Li J, Liu Y, Chen X, Kang Q, Zhao J, Li W, Acta Anaesthesiol Scand 2009 53 1184 1191 10.1111/j.1399-6576.2009.02024.x 19650809
40. Retinal pigment epithelial phenotype induced in human adipose tissue-derived mesenchymal stromal cells. Vossmerbaeumer U, Ohnesorge S, Kuehl S, Haapalahti M, Kluter H, Jonas JB, Thierse HJ, Bieback K, Cytotherapy 2009 11 177 188 10.1080/14653240802714819 19241195
41. Adenovirally transduced bone marrow stromal cells differentiate into pigment epithelial cells and induce rescue effects in RCS rats. Arnhold S, Heiduschka P, Klein H, Absenger Y, Basnaoglu S, Kreppel F, Henke-Fahle S, Kochanek S, Bartz-Schmidt KU, Addicks K, Schraermeyer U, Invest Ophthalmol Vis Sci 2006 47 4121 4129 10.1167/iovs.04-1501 16936132 (Pubitemid 46044331)
42. Induced pluripotent stem cell lines derived from human somatic cells. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA, Science 2007 318 1917 1920 10.1126/science.1151526 18029452
43. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats - Similarities to astrocyte grafts. Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ, Proc Natl Acad Sci USA 1998 95 3908 3913 10.1073/pnas.95.7.3908 9520466 (Pubitemid 28173227)
44. Mesenchymal progenitor cells in human umbilical cord blood. Erices A, Conget P, Minguell JJ, Br J Haematol 2000 109 235 242 10.1046/j.1365-2141.2000. 01986.x 10848804 (Pubitemid 30340601)
45. Generation of human induced pluripotent stem cells in the absence of exogenous Sox2. Li W, Zhou H, Abujarour R, Zhu S, Young Joo J, Lin T, Hao E, Schöler HR, Hayek A, Ding S, Stem Cells 2009 27 2992 3000 19839055
46. Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Inoue Y, Iriyama A, Ueno S, Takahashi H, Kondo M, Tamaki Y, Araie M, Yanagi Y, Exp Eye Res 2007 85 234 241 10.1016/j.exer.2007.04.007 17570362 (Pubitemid 47087799)
47. Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model. Zwart I, Hill AJ, Al-Allaf F, Shah M, Girdlestone J, Sanusi AB, Mehmet H, Navarrete R, Navarrete C, Jen LS, Exp Neurol 2009 216 439 448 10.1016/j.expneurol.2008.12.028 19320003
48. Non-invasive stem cell therapy in a rat model for retinal degeneration and vascular pathology. Wang S, Lu B, Girman S, Duan J, McFarland T, Zhang QS, Grompe M, Adamus G, Appukuttan B, Lund R, PLoS ONE 2010 5 9200 10.1371/journal.pone.0009200 20169166
49. A therapeutic strategy for choroidal neovascularization based on recruitment of mesenchymal stem cells to the sites of lesions. Hou HY, Liang HL, Wang YS, Zhang ZX, Wang BR, Shi YY, Dong X, Cai Y, Mol Ther 2010 18 1837 1845 10.1038/mt.2010.144 20647999
50. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007 131 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
51. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Zhang D, Jiang W, Liu M, Sui X, Yin X, Chen S, Shi Y, Deng H, Cell Res 2009 19 429 438 10.1038/cr.2009.28 19255591
52. Functional cardiomyocytes derived from human induced pluripotent stem cells. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ, Circ Res 2009 104 30 41 10.1161/CIRCRESAHA.108.192237 19213953
53. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, Jaenisch R, Science 2007 318 1920 1923 10.1126/science.1152092 18063756
54. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Xu D, Alipio Z, Fink LM, Adcock DM, Yang J, Ward DC, Ma Y, Proc Natl Acad Sci USA 2009 106 808 813 10.1073/pnas.0902558106 19139414
55. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R, Proc Natl Acad Sci USA 2008 105 5856 5861 10.1073/pnas.0801677105 18391196 (Pubitemid 351758462)
56. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Meyer JS, Shearer RL, Capowski EE, Wright LS, Wallace KA, McMillan EL, Zhang SC, Gamm DM, Proc Natl Acad Sci USA 2009 106 16698 16703 10.1073/pnas.0905245106 19706890
57. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Buchholz DE, Hikita ST, Rowland TJ, Friedrich AM, Hinman CR, Johnson LV, Clegg DO, Stem Cells 2009 27 2427 2434 10.1002/stem.189 19658190
58. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. Carr AJ, Vugler AA, Hikita ST, Lawrence JM, Gias C, Chen LL, Buchholz DE, Ahmado A, Semo M, Smart MJ, Hasan S, da Cruz L, Johnson LV, Clegg DO, Coffey PJ, PLoS One 2009 4 8152 10.1371/journal.pone.0008152 19997644
59. Immunogenicity of induced pluripotent stem cells. Zhao T, Zhang ZN, Rong Z, Xu Y, Nature 2011 474 212 215 21572395
60. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Shi Y, Desponts C, Do JT, Hahm HS, Schöler HR, Ding S, Cell Stem Cell 2008 3 568 574 10.1016/j.stem.2008.10. 004 18983970
61. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämäläinen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung HK, Nagy A, Nature 2009 458 766 770 10.1038/nature07863 19252478
62. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K, Nature 2009 458 771 775 10.1038/nature07864 19252477
63. Human induced pluripotent stem cells free of vector and transgene sequences. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA, Science 2009 324 797 801 10.1126/science.1172482 19325077
64. Non cell-autonomous reprogramming of adult ocular progenitors: generation of pluripotent stem cells without exogenous transcription factors. Balasubramanian S, Babai N, Chaudhuri A, Qiu F, Bhattacharya S, Dave BJ, Parameswaran S, Carson SD, Thoreson WB, Sharp JG, Rao M, Ahmad I, Stem Cells 2009 27 3053 3062 19859985
65. Generation of induced pluripotent stem cells from human blood. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, Daley GQ, Blood 2009 113 5476 5479 10.1182/blood-2009-02-204800 19299331
66. Stem cell therapy and the retina. MacLaren RE, Pearson RA, Eye 2007 21 1352 1359 10.1038/sj.eye.6702842 17914439 (Pubitemid 47534749)
67. Three-dimensional early retinal progenitor 3D tissue constructs derived from human embryonic stem cells. Nistor G, Seiler MJ, Yan F, Ferguson D, Keirstead HS, J Neurosci Methods 2010 190 63 70 10.1016/j.jneumeth.2010.04.025 20447416
68. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Lu B, Malcuit C, Wang S, Girman S, Francis P, Lemieux L, Lanza R, Lund R, Stem Cells 2009 27 2126 2135 10.1002/stem.149 19521979
69. Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Idelson M, Alper R, Obolensky A, Ben-Shushan E, Hemo I, Yachimovich-Cohen N, Khaner H, Smith Y, Wiser O, Gropp M, Cohen MA, Even-Ram S, Berman-Zaken Y, Rechavi G, Banin E, Reubinoff B, Cell Stem Cell 2009 5 396 408 10.1016/j.stem.2009.07.002 19796620
70. Embryonic stem cells and retinal repair. Vugler A, Lawrence J, Walsh J, Carr A, Gias C, Semo M, Ahmado A, da Cruz L, Andrews P, Coffey P, Mech Dev 2007 124 807 829 10.1016/j.mod.2007.08.002 17881192 (Pubitemid 350051369)
71. Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior. Klassen HJ, Ng TF, Kurimoto Y, Kirov I, Shatos M, Coffey P, Young MJ, Invest Ophthalmol Vis Sci 2004 45 4167 4173 10.1167/iovs.04-0511 15505071 (Pubitemid 39411176)
72. Stem cells for retinal replacement therapy. Stern JH, Temple S, Neurotherapeutics 2011 8 736 743 10.1007/s13311-011-0077-6 21948217
73. Neural retina degeneration followed by regeneration from surviving retinal pigment cells in grafted adult salamander eyes. Stone LS, Anat Rec 1950 106 89 109 10.1002/ar.1091060108 15404757
74. Retinal stem cells in the adult mammalian eye. Tropepe V, Coles BL, Chiasson BJ, Horsford DJ, Elia AJ, McInnes RR, van der Kooy D, Science 2000 287 2032 2036 10.1126/science.287.5460.2032 10720333 (Pubitemid 30158683)
75. Identification of neural progenitors in the adult mammalian eye. Ahmad I, Tang L, Pham H, Biochem Biophys Res Commun 2000 270 517 521 10.1006/bbrc.2000.2473 10753656 (Pubitemid 30446867)
76. Cells previously identified as retinal stem cells are pigmented ciliary epithelial cells. Cicero SA, Johnson D, Reyntjens S, Frase S, Connell S, Chow LM, Baker SJ, Sorrentino BP, Dyer MA, Proc Natl Acad Sci USA 2009 106 6685 6690 10.1073/pnas.0901596106 19346468
77. Persistent progenitors at the retinal margin of ptc+/-mice. Moshiri A, Reh TA, J Neurosci 2004 24 229 237 10.1523/JNEUROSCI.2980-03.2004 14715955 (Pubitemid 38181687)
78. Stimulation of neural regeneration in the mouse retina. Karl MO, Hayes S, Nelson BR, Tan K, Buckingham B, Reh TA, Proc Natl Acad Sci USA 2008 105 19508 19513 10.1073/pnas.0807453105 19033471
79. Neural stem cell properties of Muller glia in the mammalian retina: regulation by Notch and Wnt signaling. Das AV, Mallya KB, Zhao X, Ahmad F, Bhattacharya S, Thoreson WB, Hegde GV, Ahmad I, Dev Biol 2006 299 283 302 10.1016/j.ydbio.2006.07.029 16949068 (Pubitemid 44550105)
80. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Rafii S, Lyden D, Nat Med 2003 9 702 712 10.1038/nm0603-702 12778169 (Pubitemid 36749219)
81. Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. Medina RJ, O'Neill CL, Sweeney M, Guduric-Fuchs J, Gardiner TA, Simpson DA, Stitt AW, BMC Med Genomics 2010 3 18 10.1186/1755-8794-3-18 20465783
82. Endothelial progenitor cells contribute to vascular repair in the ischaemic retina. Medina RJ, O'Neill CL, O'Doherty TM, Guduric-Fuchs J, Gardiner TA, Stitt AW, Heart 2011 97 7
83. Surgically relevant aspects of stem cell paracrine effects. Crisostomo PR, Markel TA, Wang Y, Meldrum DR, Surgery 2008 143 577 581 10.1016/j.surg.2007. 10.015 18436004
84. VEGF is critical for stem cellmediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Markel TA, Wang Y, Herrmann JL, Crisostomo PR, Wang M, Novotny NM, Herring CM, Tan J, Lahm T, Meldrum DR, Am J Physiol Heart Circ Physiol 2008 295 2308 2314 10.1152/ajpheart.00565.2008 18849336
85. Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production. Markel TA, Crisostomo PR, Wang M, Herring CM, Meldrum DR, Am J Physiol Gastrointest Liver Physiol 2007 293 657 662 10.1152/ajpgi.00230.2007 17640973 (Pubitemid 47605914)
86. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Oh JY, Kim MK, Shin MS, Lee HJ, Ko JH, Wee WR, Lee JH, Stem Cells 2008 26 1047 1055 10.1634/stemcells.2007- 0737 18192235
87. Tumor-stroma interactions influence cytokine expression and matrix metalloproteinase activities in paired primary and metastatic head and neck cancer cells. Koontongkaew S, Amornphimoltham P, Yapong B, Cell Biol Int 2009 33 165 173 10.1016/j.cellbi.2008.10.009 18996211
88. Transplantation of the RPE in AMD. Binder S, Stanzel BV, Krebs I, Glittenberg C, Prog Retin Eye Res 2007 26 516 515 10.1016/j.preteyeres.2007.02. 002 17532250 (Pubitemid 47302351)
89. Human retinal pigment epithelium (RPE) transplantation: outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomized clinical study. Falkner-Radler CI, Krebs I, Glittenberg C, Povazay B, Drexler W, Graf A, Binder S, Br J Ophthalmol 2011 95 370 375 10.1136/bjo.2009.176305 20610478
90. Stem cells as a therapeutic tool for the blind: biology and future prospects. Singh MS, Maclaren RE, Proc Biol Sci 2011 278 3009 3016 10.1098/rspb.2011.1028 21813553
91. Biology and therapeutic potential of adult retinal stem cells. Ballios BG, van der Kooy D, Can J Ophthalmol 2010 45 342 351 10.3129/i10-070 20648091
92. Stem-cell therapy for retinal diseases. Siqueira RC, Embryonic Stem Cells-Differentiation and Pluripotent Alternatives Rijeka, Croatia: InTech, Kallos MS, 2011 http://www.intechopen.com/articles/show/title/stem-cell-therapy- for-retinal-diseases
93. Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia/reperfusion. Li N, Li XR, Yuan JQ, Graefes Arch Clin Exp Ophthalmol 2009 247 503 514 10.1007/s00417-008-1009-y 19084985
94. Intravitreous transplantation of encapsulated fibroblasts secreting the human fibroblast growth factor 2 delays photoreceptor cell degeneration in Royal College of Surgeons rats. Uteza Y, Rouillot JS, Kobetz A, Marchant D, Pecqueur S, Arnaud E, Prats H, Honiger J, Dufier JL, Abitbol M, Neuner-Jehle M, Proc Natl Acad Sci USA 1999 96 3126 3131 10.1073/pnas.96.6.3126 10077648 (Pubitemid 29148855)
95. Effects of bone marrow mesenchymal stem cell transplantation on light-damaged retina. Zhang Y, Wang W, Invest Ophthalmol Vis Sci 2010 51 3742 3748 10.1167/iovs.08-3314 20207980
96. Bone marrow-derived stem cells can differentiate into retinal cells in injured rat retina. Tomita M, Adachi Y, Yamada H, Takahashi K, Kiuchi K, Oyaizu H, Ikebukuro K, Kaneda H, Matsumura M, Ikehara S, Stem Cells 2002 20 279 283 10.1634/stemcells.20-4-279 12110696 (Pubitemid 34765086)
97. Embryonic stem cell-derived neural progenitors incorporate into degenerating retina and enhance survival of host photoreceptors. Meyer JS, Katz ML, Maruniak JA, Kirk MD, Stem Cells 2006 24 274 283 10.1634/stemcells.2005-0059 16123383 (Pubitemid 44464795)
98. Transplantation of quantum dotlabelled bone marrow-derived stem cells into the vitreous of mice with laser-induced retinal injury: survival, integration and differentiation. Wang HC, Brown J, Alayon H, Stuck BE, Vision Res 2010 50 665 673 10.1016/j.visres.2009.09.003 19782698
99. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Johnson TV, Bull ND, Hunt DP, Marina N, Tomarev SI, Martin KR, Invest Ophthalmol Vis Sci 2010 51 2051 2059 10.1167/iovs.09-4509 19933193
100. Advanced Cell Technology, Inc. homepage. http://www.advancedcell.com